Ardelyx Stock Today
| ARDX Stock | USD 6.39 0.12 1.84% |
Performance0 of 100
| Odds Of DistressLess than 6
|
Ardelyx is trading at 6.39 as of the 24th of April 2024; that is -1.84 percent down since the beginning of the trading day. The stock's open price was 6.51. Ardelyx has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Ardelyx are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of March 2023 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of June 2014 | Category Healthcare | Classification Health Care |
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. The company has 232.69 M outstanding shares of which 35.02 M shares are presently shorted by private and institutional investors with about 6.33 trading days to cover. More on Ardelyx
Moving together with Ardelyx Stock
| 0.67 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.74 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Ardelyx Stock
| 0.61 | ELYM | Eliem Therapeutics | PairCorr |
| 0.6 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
| 0.59 | OPT | Opthea | PairCorr |
| 0.56 | AVTE | Aerovate Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.43 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.43 | SUPN | Supernus Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 1st of May 2024
Ardelyx Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ardelyx's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ardelyx or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | Michael Raab | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Biotech (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Ardelyx report their recommendations after researching Ardelyx's financial statements, talking to executives and customers, or listening in on Ardelyx's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Ardelyx. The Ardelyx consensus assessment is calculated by taking the average forecast from all of the analysts covering Ardelyx. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Ardelyx's financial statements, Ardelyx may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Ardelyx is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ardelyx's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ardelyx's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ardelyx's financial leverage. It provides some insight into what part of Ardelyx's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ardelyx (ARDX) is traded on NASDAQ Exchange in USA. It is located in 400 Fifth Avenue, Waltham, MA, United States, 02451 and employs 267 people. Ardelyx is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.51 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ardelyx's market, we take the total number of its shares issued and multiply it by Ardelyx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ardelyx conducts business under Biotechnology sector and is part of Health Care industry. The entity has 232.69 M outstanding shares of which 35.02 M shares are presently shorted by private and institutional investors with about 6.33 trading days to cover.
Ardelyx currently holds about 90.62 M in cash with (89.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Check Ardelyx Probability Of Bankruptcy
Ownership AllocationArdelyx retains a total of 232.69 Million outstanding shares. Over half of Ardelyx's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Ardelyx. Please watch out for any change in the institutional holdings of Ardelyx as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Ardelyx Ownership Details
Ardelyx Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Ardelyx jumping above the current price in 90 days from now is about 98.0%. The Ardelyx probability density function shows the probability of Ardelyx stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.4252. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ardelyx will likely underperform. Additionally, ardelyx has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Ardelyx to move above the current price in 90 days from now is about 98.0 (This Ardelyx probability density function shows the probability of Ardelyx Stock to fall within a particular range of prices over 90 days) .
Ardelyx Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Ardelyx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ardelyx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ardelyx's value.| Instituion | Recorded On | Shares | |
| T. Rowe Price Associates, Inc. | 2023-12-31 | 2.3 M | |
| Goldman Sachs Group Inc | 2023-12-31 | 2.2 M | |
| Northern Trust Corp | 2023-12-31 | 2.2 M | |
| Barclays Plc | 2023-12-31 | 2.2 M | |
| Nuveen Asset Management, Llc | 2023-12-31 | 2.1 M | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 1.8 M | |
| J. Goldman & Co Lp | 2023-12-31 | 1.6 M | |
| Rafferty Asset Management, Llc | 2023-12-31 | 1.4 M | |
| Lion Point Capital, Lp | 2023-12-31 | 1.2 M | |
| Hhg Plc | 2023-12-31 | 24.7 M | |
| State Street Corporation | 2023-12-31 | 17.1 M |
Ardelyx Historical Income Statement
Ardelyx Income Statement is one of the three primary financial statements used for reporting Ardelyx's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Ardelyx revenue and expense. Ardelyx Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Ardelyx's Reconciled Depreciation is fairly stable compared to the past year. View More FundamentalsArdelyx Stock Against Markets
Picking the right benchmark for Ardelyx stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ardelyx stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ardelyx is critical whether you are bullish or bearish towards Ardelyx at a given time. Please also check how Ardelyx's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ardelyx without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Ardelyx Corporate Directors
Ardelyx corporate directors refer to members of an Ardelyx board of directors. The board of directors generally takes responsibility for the Ardelyx's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Ardelyx's board members must vote for the resolution. The Ardelyx board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gordon Ringold | Independent Director | Profile | |
| Robert Bazemore | Independent Director | Profile | |
| Geoffrey Block | Director | Profile | |
| Richard Rodgers | Independent Director | Profile |
How to buy Ardelyx Stock?
Before investing in Ardelyx, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Ardelyx. To buy Ardelyx stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Ardelyx. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Ardelyx stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Ardelyx stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Ardelyx stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Ardelyx, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.
Already Invested in Ardelyx?
The danger of trading Ardelyx is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ardelyx is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ardelyx. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ardelyx is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ardelyx offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ardelyx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ardelyx Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ardelyx Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ardelyx. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.Note that the Ardelyx information on this page should be used as a complementary analysis to other Ardelyx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Ardelyx Stock analysis
When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Ardelyx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ardelyx. If investors know Ardelyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ardelyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Revenue Per Share 0.567 | Quarterly Revenue Growth (0.22) | Return On Assets (0.16) | Return On Equity (0.50) |
The market value of Ardelyx is measured differently than its book value, which is the value of Ardelyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ardelyx's value that differs from its market value or its book value, called intrinsic value, which is Ardelyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ardelyx's market value can be influenced by many factors that don't directly affect Ardelyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ardelyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ardelyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ardelyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.